Tomimoto, Hidekazu

White Matter Lesions and Glial Activation in a Novel Mouse Model of Chronic Cerebral Hypoperfusion

Shibata, M., Ohtani, R., Ihara, M., & Tomimoto, H. (2004) · Stroke

Neurological Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 583

Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts

Okamoto, Y., Yamamoto, T., Kalaria, R. N., Senzaki, H., Maki, T., Hase, Y., Kitamura, A., Washida, K., Yamada, M., Ito, H., et al. (2012) · Acta Neuropathologica

Intracerebral and Subarachnoid Hemorrhage ResearchNeurological Disease Mechanisms and Treatments

Cited by 249

Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer’s disease patients

Tomimoto, H., Akiguchi, I., Suenaga, T., Nishimura, M., Wakita, H., Nakamura, S., & Kimura, J. (1996) · Stroke

Barrier Structure and Function StudiesCerebrovascular and genetic disorders

Cited by 204

Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat

Wakita, H., Tomimoto, H., Akiguchi, I., Matsuo, A., Lin, J.-X., Ihara, M., & McGeer, P.-L. (2002) · Brain Research

Neurological Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 197

Galantamine-induced Amyloid-β Clearance Mediated via Stimulation of Microglial Nicotinic Acetylcholine Receptors

Takata, K., Kitamura, Y., Saeki, M., Terada, M., Kagitani, S., Kitamura, R., Fujikawa, Y., Maelicke, A., Tomimoto, H., Taniguchi, T., et al. (2010) · Journal of Biological Chemistry

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 176

Blood-brain barrier disruption in white matter lesions in a rat model of chronic cerebral hypoperfusion

Ueno, M., Tomimoto, H., Akiguchi, I., Wakita, H., & Sakamoto, H. (2002) · Journal of Cerebral Blood Flow & Metabolism

Barrier Structure and Function StudiesNeurological Disease Mechanisms and Treatments

Cited by 147

Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter

Ihara, M., Tomimoto, H., Kinoshita, M., Oh, J., Noda, M., Wakita, H., Akiguchi, I., & Shibasaki, H. (2001) · Journal of Cerebral Blood Flow & Metabolism

Neurological Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 115

Attenuation of brain damage and cognitive impairment by direct renin inhibition in mice with chronic cerebral hypoperfusion

Dong, Y.-F., Kataoka, K., Toyama, K., Sueta, D., Koibuchi, N., Yamamoto, E., Yata, K., Tomimoto, H., Ogawa, H., & Kim-Mitsuyama, S. (2011) · Hypertension

Neurological Disease Mechanisms and TreatmentsRenin-Angiotensin System Studies

Cited by 109

Chronic cerebral hypoperfusion accelerates amyloid β deposition in APPSwInd transgenic mice

Kitaguchi, H., Tomimoto, H., Ihara, M., Shibata, M., Uemura, K., Kalaria, R. N., Kihara, T., Asada-Utsugi, M., Kinoshita, A., & Takahashi, R. (2009) · Brain Research

Alzheimer's disease research and treatmentsNeurological Disease Mechanisms and Treatments

Cited by 108

Blood-brain barrier dysfunction in Binswanger’s disease; an immunohistochemical study

Akiguchi, I., Tomimoto, H., Suenaga, T., Wakita, H., & Budka, H. (1998) · Acta Neuropathologica

Cerebrovascular and genetic disordersBarrier Structure and Function Studies

Cited by 104

Angiogenic and vasoprotective effects of adrenomedullin on prevention of cognitive decline after chronic cerebral hypoperfusion in mice

Maki, T., Ihara, M., Fujita, Y., Nambu, T., Miyashita, K., Yamada, M., Washida, K., Nishio, K., Ito, H., Harada, H., et al. (2011) · Stroke

Neurological Disease Mechanisms and TreatmentsNeuropeptides and Animal Physiology

Cited by 88

Involvement of WAVE Accumulation in Aβ/APP Pathology-Dependent Tangle Modification in Alzheimer’s Disease

Takata, K., Kitamura, Y., Nakata, Y., Matsuoka, Y., Tomimoto, H., Taniguchi, T., & Shimohama, S. (2009) · The American Journal of Pathology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 36

Electron microscopic investigation of the cerebral cortex after cerebral ischemia and reperfusion in the gerbil

Tomimoto, H., & Yanagihara, T. (1992) · Brain Research

Neurological Disease Mechanisms and TreatmentsAcute Ischemic Stroke Management

Cited by 34

Topographical and cytopathological lesion analysis of the white matter in Binswanger?s disease brains

Akiguchi, I., Tomimoto, H., Wakita, H., Kawamoto, Y., Matsuo, A., Ohnishi, K., Watanabe, T., & Budka, H. (2004) · Acta Neuropathologica

Cerebrovascular and genetic disordersNeurological Disease Mechanisms and Treatments

Cited by 25

Small artery dementia in Japan: radiological differences between CADASIL, leukoaraiosis and Binswanger’s disease

Tomimoto, H., Ohtani, R., Wakita, H., Lin, J.-X., Ihara, M., Miki, Y., Oshima, F., Murata, T., Ishibashi, K., Suenaga, T., et al. (2006) · Dementia and Geriatric Cognitive Disorders

Cerebrovascular and genetic disordersNeurological Disease Mechanisms and Treatments

Cited by 20

Clinical and neuropathological findings in a patient with familial Alzheimer disease showing a mutation in the PSEN1 gene

Niwa, A., Matsuo, K., Shindo, A., Yata, K., Shiraishi, T., & Tomimoto, H. (2013) · Neuropathology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 16